TrialCPT: pharmacometrics & systems pharmacology2025

Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study.

Aurore Carrot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.